Product Information

ACYCLOVIR 400 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0955 per EA under NDC 31722077705. Its NADAC has been published 654 times since May 7, 2014.

FDA first approved this application on Oct 29, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ACYCLOVIR 400 MG TABLET

Acyclovir
$0.0955per EA

Strength

400 mg/1

NDC

31722077705

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ACYCLOVIR

Approval Type

Generic (ANDA)

FDA Application

ANDA203834

FDA Approved

10/29/2013

TE Code

AB

On Market Since

11/29/2013

Price Statistics

The NADAC for ACYCLOVIR 400 MG TABLET has been published 654 times since May 7, 2014, and over the history we have for it it has declined 18.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0955 per EA
All-time high$0.1245 (Jan 13, 2021)
All-time low$0.0689 (Nov 20, 2024)
52-week high$0.1007
52-week low$0.0912
Median price$0.1003
Average price$0.0997
Largest weekly change-28.6% (Nov 20, 2024)
Weeks tracked654
Tracking sinceMay 7, 2014

Price History

1W

0.0%

1M

-0.7%

3M

-4.5%

6M

-2.6%

1Y

+3.8%

3Y

-10.5%

5Y

-13.2%

All

-18.3%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ACYCLOVIR 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ACYCLOVIR 400 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0955 per EA (NDC 31722077705), effective Nov 11, 2026.

How has the price of ACYCLOVIR 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for ACYCLOVIR 400 MG TABLET has declined 18.3%. It has been tracked across 654 weekly CMS publications since May 7, 2014.

What are the highest and lowest recorded NADAC prices for ACYCLOVIR 400 MG TABLET?

Since May 7, 2014, the NADAC for ACYCLOVIR 400 MG TABLET has ranged from a low of $0.0689 (Nov 20, 2024) to a high of $0.1245 (Jan 13, 2021), with a median of $0.1003 per EA.

Are there cheaper alternatives to ACYCLOVIR 400 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACYCLOVIR 400 MG TABLET, is $0.0779 per EA — about 18% below ACYCLOVIR 400 MG TABLET.

Who manufactures ACYCLOVIR 400 MG TABLET?

ACYCLOVIR 400 MG TABLET (NDC 31722077705) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.